EUVIMEDEUVIMED entdecken
Crossref

COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

Wolfgang Hohenforst-Schmidt, Kalliopi Domvri, Nikolaos Zogas, Paul Zarogoulidis, Savvas Petanidis, Efrosini Kioseoglou, George Zachariadis, Stylianos Kakolyris, Konstantinos Porpodis, Mina Gaga, Haidong Huang, Theodor Kontakiotis und 1 weitere

Oncomedicine · 2017

DOI: 10.7150/oncm.17020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Wolfgang Hohenforst-Schmidt und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hohenforst-Schmidt, W., Domvri, K., Zogas, N., Zarogoulidis, P., Petanidis, S., Kioseoglou, E., Zachariadis, G., Kakolyris, S., Porpodis, K., Gaga, M., Huang, H., Kontakiotis, T., & Zarogoulidis, K. (2017). COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer. Oncomedicine. https://doi.org/10.7150/oncm.17020

Vancouver

Hohenforst-Schmidt W, Domvri K, Zogas N, Zarogoulidis P, Petanidis S, Kioseoglou E, et al. COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer. Oncomedicine. 2017. doi:10.7150/oncm.17020

BibTeX
@article{HohenforstSchmidt2017,
  author = {Hohenforst-Schmidt, Wolfgang and Domvri, Kalliopi and Zogas, Nikolaos and Zarogoulidis, Paul and Petanidis, Savvas and Kioseoglou, Efrosini and Zachariadis, George and Kakolyris, Stylianos and Porpodis, Konstantinos and Gaga, Mina and Huang, Haidong and Kontakiotis, Theodor and Zarogoulidis, Konstantinos},
  title = {COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer},
  journal = {Oncomedicine},
  year = {2017},
  doi = {10.7150/oncm.17020}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche